Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.
about
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studiesCoronary artery revascularization in patients with diabetes mellitusInsulin initiation in patients with type 2 diabetes mellitus: treatment guidelines, clinical evidence and patterns of use of basal vs premixed insulin analoguesOsteoprotegerin (OPG) as a biomarker for diabetic cardiovascular complications.Update on RAAS Modulation for the Treatment of Diabetic Cardiovascular DiseaseExpanding the scope of risk assessment: methods of studying differential vulnerability and susceptibilityCause-specific cardiovascular risk associated with nonsteroidal anti-inflammatory drugs among myocardial infarction patients--a nationwide studyAssociation of Cardiometabolic Multimorbidity With MortalityAncient records and modern research on the mechanisms of chinese herbal medicines in the treatment of diabetes mellitusNon-steroidal anti-inflammatory drug use is associated with increased risk of out-of-hospital cardiac arrest: a nationwide case–time–control studyCoronary Endothelial Dysfunction in Women With Type 2 Diabetes Measured by Coronary Phase Contrast Flow Velocity Magnetic Resonance Imaging.Concordance between administrative health data and medical records for diabetes status in coronary heart disease patients: a retrospective linked data study.Short-term mortality risk of serum potassium levels in hypertension: a retrospective analysis of nationwide registry data.Evaluation of the CHADS2 risk score on short- and long-term all-cause and cardiovascular mortality after syncope.Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study).Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008Diabetes medications and cancer risk: review of the literatureMyocardial blood flow quantification for evaluation of coronary artery disease by positron emission tomography, cardiac magnetic resonance imaging, and computed tomography.Impact of diabetes duration and degree of carotid artery stenosis on major adverse cardiovascular events: a single-center, retrospective, observational cohort studyDyslipidemia, kidney disease, and cardiovascular disease in diabetic patients.Are statin trials in diabetes representative of real-world diabetes care: a population-based study on statin initiators in FinlandIntroduction of the DiaGene study: clinical characteristics, pathophysiology and determinants of vascular complications of type 2 diabetes.Refining Long-Term Prediction of Cardiovascular Risk in Diabetes - The VILDIA Score.Diabetes is an independent predictor of survival 17 years after myocardial infarction: follow-up of the TRACE registry.Long-term cardiovascular risk in type 2 diabetic compared with nondiabetic first acute myocardial infarction patients: a population-based cohort study in southern Europe.Body mass index and risk of perioperative cardiovascular adverse events and mortality in 34,744 Danish patients undergoing hip or knee replacement.Relationship of dysglycemia to acute myocardial infarct size and cardiovascular outcome as determined by cardiovascular magnetic resonance.Effect of depression on mortality and cardiovascular morbidity in type 2 diabetes mellitus after 3 years follow up. The DIADEMA study protocol.A retrospective, pooled data analysis of the safety of pegaptanib sodium in the treatment of age-related macular degeneration in subjects with or without diabetes mellitusEfficacy and safety of saxagliptin as add-on therapy in type 2 diabetes.New and known type 2 diabetes as coronary heart disease equivalent: results from 7.6 year follow up in a Middle East population.Observational study of the association of first insulin type in uncontrolled type 2 diabetes with macrovascular and microvascular disease.Effects of different protein sources on plasminogen inhibitor-1 and factor VII coagulant activity added to a fat-rich meal in type 2 diabetes.Statin adherence and the risk of major coronary events in patients with diabetes: a nested case-control study.Increased risk of myocardial infarction in depressed patients with type 2 diabetes.Diabetes and coronary heart disease as risk factors for mortality in older adults.National Background is Associated with Disparities in Initiation and Persistence to Statin Treatment in Subjects with Diabetes in Denmark.Sex differences in cardiovascular mortality in diabetics and nondiabetic subjects: a population-based study (Italy).Targeted inhibition of calpain reduces myocardial hypertrophy and fibrosis in mouse models of type 1 diabetesEffects of Family Meal Frequency on Risk Factors for Cardiovascular Disease in Korean Elderly Males and Females.
P2860
Q24608301-4B25845D-FC4B-4FE1-B8B0-9ABA9F1F60EDQ26824002-E45F583B-0F37-4286-B1E8-346B3438CAF7Q26861313-6BA52A99-2D33-4A8A-B958-E687AA8368F4Q27692635-D9D40880-CFE1-4F9B-89E5-9441C8CC8041Q28077454-CE1A6E15-FF73-46E7-BCCB-8FF4245FE528Q28393941-0111B2E5-DB92-47E5-AC02-29E5E44D75F6Q28485380-2E05FAA7-2CC6-4778-B02C-B0385B3F3E7FQ28606934-9DB4F4FA-7785-4692-9BE4-D8ED5B180C9DQ28652397-B6950391-35A8-4C67-9B6D-A8882AF759FBQ28969131-DFA2C3F1-D778-43B3-8AA2-FBEFF2D84665Q30373293-DABCAD62-79AE-412B-8550-8A7ED42FA4BCQ30670756-5B3A7FB2-A94B-4F87-AB15-1F7EB2C720FDQ31159433-A03C02D6-DC42-478F-BF59-592DF6DEA799Q33162429-3264E4BE-73A8-4DD8-A7BD-BF196B2DD6F8Q33404972-A9378C8B-AE91-43E6-8459-353F84926654Q33602366-1001F36A-0A2F-4A98-B222-8345D15AB48AQ33714881-34C4A72E-CAB0-4587-B706-9064E3185C82Q33741484-4E78FA38-A377-48BC-8463-5FFE862FDCD4Q33771349-7717AD5C-6605-4D89-9827-220A924C04A3Q33776181-EB1B11BB-EE4C-462C-869F-30C698DCCEF9Q33795544-63A1F4AB-F892-4F9B-A176-331D8A8A20A5Q33814542-0B04D354-EE22-4CF5-8A3E-0EFBA7D35E0BQ33875341-FC9E4B20-C178-4B64-B083-A4BF24504B44Q33945039-B1E4973C-C13F-4FD3-97E5-00996008973DQ34084551-8F55A75F-A935-4CA6-B5F6-213C49E106DFQ34185318-6DADCA23-0285-432E-A594-4FB4F1086CA8Q34322273-AFC5AAB7-2D33-479E-81D5-07E3E2242B2EQ34356863-B47AE45A-E4E9-443A-B093-5EEB1F20CC85Q34370043-D076054C-1009-4572-9140-29A8C0997DCEQ34454269-33DF3C6B-AAB7-40AA-93AA-86CF686257C9Q34468205-45F1BB0E-AB4A-418B-9CA3-8D309F063BE9Q34482881-42924CC2-A57F-4800-803F-D04A235224B6Q34703186-81A60A7B-585E-4A53-9707-0FAB966BF919Q34976504-CEABC283-18DE-4B7C-8696-F255D7F065C4Q35123387-72B54076-E13F-4E47-B208-CBA688FAAD5DQ35134400-9FF8B121-C629-4DB2-B4B4-01BFF29972FBQ35155256-EAF9449E-A193-489C-96F3-A03EB72A5DC1Q35271574-ED83F27B-1794-49C7-9390-435D66F61B51Q35404816-91FEADCF-396C-4A91-B8C1-006454802357Q35668248-E85E60F8-8C6F-4BEE-9920-5BAACDAC34B1
P2860
Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Diabetes patients requiring gl ...... n study of 3.3 million people.
@en
type
label
Diabetes patients requiring gl ...... n study of 3.3 million people.
@en
prefLabel
Diabetes patients requiring gl ...... n study of 3.3 million people.
@en
P2093
P50
P921
P1433
P1476
Diabetes patients requiring gl ...... n study of 3.3 million people.
@en
P2093
Allan Vaag
Fredrik Folke
Jeppe N Rasmussen
Mette Madsen
Morten Lock Hansen
Pernille Buch
Steen Z Abildstrøm
Søren Rasmussen
Tina Ken Schramm
P304
P356
10.1161/CIRCULATIONAHA.107.720847
P407
P577
2008-03-31T00:00:00Z